Molecular detection of rifampin and isoniazid resistance to guide chronic TB patient management in Burkina Faso

Overview of attention for article published in BMC Infectious Diseases, August 2009

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

policy: 1 policy source

Citations

dimensions_citation: 19 Dimensions

Readers on

mendeley: 87 Mendeley

Summary Policy documents Dimensions citations

So far, Altmetric has seen 3 policy documents that reference this research output.

WHO consolidated guidelines on tuberculosis: module 3: diagnosis – rapid diagnostics for tuberculosis detection: web annex 1: list of studies included in systematic reviews

Cited by World Health Organization on 01 Jul 2021

The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.

WHO consolidated guidelines on tuberculosis: module 3: diagnosis - rapid diagnostics for tuberculosis detection: web annex 1: list of studies included in systematic reviews

Cited by World Health Organization on 04 Sep 2020

The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.

The use of molecular line probe assay for the detection of resistance to isoniazid and rifampicin: policy update

Cited by World Health Organization on 20 Oct 2016

The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.